首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and efficacy of romiplostim in patients with eltrombopag‐resistant or ‐intolerant immune thrombocytopenia
Authors:Shokichi Tsukamoto  Chiaki Nakaseko  Masahiro Takeuchi  Kyoya Kumagai  Tsunehiko Komatsu  Hiroaki Tanaka  Satoru Hara  Masayuki Koizumi  Hidenori Imai  Akira Yokota  Masami Takeuchi  Koiti Inokuchi  Yasuhiro Matsuura  Nobuyuki Aotsuka  Hisashi Wakita
Affiliation:1. Department of Haematology, Chiba University Hospital, , Chiba, Japan;2. Division of Haematology‐Oncology, Chiba Cancer Centre Hospital, , Chiba, Japan;3. Department of Haematology, Teikyo University Chiba Medical Centre, , Chiba, Japan;4. Department of Haematology, Oami Municipal Hospital, , Chiba, Japan;5. Department of Haematology, Chiba Rousai Hospital, , Chiba, Japan;6. Department of Internal Medicine, Asahi General Hospital, , Chiba, Japan;7. Department of Haematology, Juntendo‐Urayasu Hospital, , Chiba, Japan;8. Department of Haematology, Chiba Aoba Municipal Hospital, , Chiba, Japan;9. Division of Haematology?Oncology, Kameda General Hospital, , Chiba, Japan;10. Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, , Chiba, Japan;11. Department of Haematology and Oncology, Japanese Red Cross Narita Hospital, , Chiba, Japan
Abstract:
Keywords:romiplostim  eltrombopag  immune thrombocytopenia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号